Inhibition of enterovirus 71 entry by peptides targeting I β-sheet of VP1 protein Ming-Liang He, Ph.D The Chinese University of Hong Kong.

Slides:



Advertisements
Similar presentations
Pathogenesis and Control of Viral Infections Chapter 30.
Advertisements

The Art of Reconstruction.  In order to survive, viruses must be able to do the following: ◦ 1. Find a host cell it can replicate in ◦ 2. Bind to that.
Picornaviruses Chapter 36. Properties Structure and composition 30 nm, icosahedral plus-strand RNA, kb RNA is polyadenylated Ten genes, eleven.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Picornaviruses. Plus Strand RNA Virus Families PICORNAVIRIDAE More than 200 viruses prevalent world-wide. cause many serious diseases of animals and man.
Influenza Sara Finestone April 8, The influenza virus causes 3-5 million cases of severe illness and up to 500,000 deaths annually.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Mol Biol Evol 2007 Vol 24: Which adaptations to human characterize the transfer from SIVcpz to HIV-1?
Virus-host interactions
Poliovirus By: Connor Nash.
General Principles De novo initiation: – RNA polymerase – RNA template – The initiating NTP and a second NTP Primer Dependant initiation – Protein primer.
Human Immunodeficiency Virus HIV causes acquired immune deficiency syndrome (AIDS) AIDS was first reported in the US in 1981 –Origin in Africa in 1950s.
Viruses that Use Reverse Transcriptase during Replication The retroviruses have an RNA genome that is converted to DNA by RT after infection. The hepadnaviruses.
Viruses Chapter Nature of Viruses All viruses have same basic structure -Nucleic acid core surrounded by capsid Nucleic acid can be DNA or RNA;
Interaction of Neurotropic Enterovirus-71 with Receptor PSGL-1 Matthew Makowski ¹, Josh Yoder ², Javier Cifuente ², Bob Ashley ², Jennifer Yoder ², Hyunwook.
Viruses Chapter 19. A Borrowed Life Virus: an infections particle incapable of replicating outside of a cell, which consists of an RNA or DNA genome enclosed.
Introduction Hepatitis C Virus
Using Comparative Genomics to Explore the Genetic Code of Influenza Sangeeta Venkatachalam.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Branches of Microbiology Bacteriology Virology Mycology Parasitology Immunology Recombinant DNA technology.
THE SARS VIRUS GENOME The Quick and the Dead?. SARS Severe Acute Respiratory Syndrome First identified in Guangdong Province, China Mortality 3-6% (45-63%
Ryan Kang Jeff Huynh Per. 5.  Virus  Subtype H5N1 influenza A strain  Usually unlikely to transfer from birds to humans  Human to Human infection.
Viruses are the smallest infectious diseases (ranging from nm) They are obligatory intracellular parasites without own metabolism (being parasites.
Scientific Reading and Writing in English discussion Shu-ying Wang, Ph.D. Dept. Microbiology and Immunology Tel: ext Fax:
Mark Fang Stanford iGEM 08-09
Acquired Immunodeficiency Syndrome AIDS
Susan L. Uprichard, PhD Director of Hepatology Research Loyola University Medical Center Department of Medicine Section of Hepatology HepNet 2013 HCV Virology.
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
Biochemistry of Hepatitis C
Spring Translation Questions? 1) How does poliovirus shutoff eukaryotic translation? 2)If eukaryotic messages are not translated how can poliovirus.
Figure 1. Schematic of picornavirus genome organization. The positive-strand RNA has the viral protein VPg covalently linked to the 5′ end of the genome.
Specific Defenses of the Host Part 2 (acquired or adaptive immunity)
HCV Protease Yasir Waheed. Discovery of Hepatitis C.
Virology 2015 RNA Virus RdRP Enzymes.
HUMAN IMMUNODEFICIENCY VIRUS AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
Interferons Induction of synthesis Induction of antiviral activity Antiviral activities induced by interferons  and  Antiviral activities induced by.
I Introduction to influenza
I Introduction to influenza Department of Health 2016 Vaccination Campaign Training workshop Presentation developed by the National Institute for Communicable.
Orthomyxoviruses Orthomyxoviridae
Abira Khan.  Changes in host cell structure 1.Cell rounding, detachment from substrate 2.Cell lysis 3.Syncytium formation 4.Inclusion body formation.
Antiviral Medications
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
The Art of Reconstruction
Virus Replication John Goulding, Imperial College London, UK
THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
A flavone-based inhibitor of in vitro human rhinovirus replication induces resistant mutations in capsid protein VP4. Céline Lacroixa, Hari Babu Bollikollac,
Structural biology of hepatitis C virus
A typical enveloped virus
Objectives To understand the general principles involved in RNA replication discussed in Chapter 6 pages To use the following + stranded RNA viruses.
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Figure 1 HCV life cycle and site of action of DAAs
The Influenza Virus Enigma
Structure of V3-containing HIV-1 gp120 core
The Rational Design of an AIDS Vaccine
Construction and analysis of the HEV-host PPI network.
Replication of human astroviruses.
Protein interactions during the flavivirus life cycle elucidated by MS-based proteomics. Protein interactions during the flavivirus life cycle elucidated.
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
New therapies on the horizon for hepatitis C
The human norovirus genome.
Innate Immune Sensing of HIV-1 by Dendritic Cells
Justin R. Bailey, Eleanor Barnes, Andrea L. Cox  Gastroenterology 
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
B19V infection of human erythroid progenitor cells (B19V life cycle).
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
Diagram of sapovirus genomic organization and the RT-PCR target regions for human sapoviruses based on the GI.1 Manchester strain (GenBank accession no.
Strategies of CMV envelope protein-mediated immune evasion.
The hantavirus life cycle.
Presentation transcript:

Inhibition of enterovirus 71 entry by peptides targeting I β-sheet of VP1 protein Ming-Liang He, Ph.D The Chinese University of Hong Kong

Enterovirus 71 (EV71)  A single stranded, non-enveloped RNA virus (~ 7.5 kb in size);  EV71 infection causes hand-foot-and-mouth disease (HFMD);  Children under 5 are highly susceptible to EV71 and easily develop central nervous system (CNS) symptoms;  As long as it causes CNS infection or symptoms, leading to neurologic sequelae, including neurological disorders, meningitis, and even death.

Hand, Foot & Mouth Disease an acute viral infection, commonly seen in infants and children

EV71 epidemiology in China The reported HFMD cases and related death in China from 2007 to No drugs, no vaccine available! Lu J et al., Crit. Rev. Microbiol. 2013

Principle of Antiviral  Block viral entry by peptides, small molecules or antibodies;  Block viral replication;  Block the assembly of virions;  Block the virion secretion;  Disturb the cellular signaling, and therefore block one or more processes in the life cycle of virus.

A C D The 3D structure of VP1-VP4 complex of EV71 (PDB ID: 3VBS) virion. VP1, VP2, VP3 and VP4 were represented in blue, red, green and yellow, respectively. I-β sheet is indicated by a big write arrow.

The VP1 structure canyon a-helix, D-β and I-β sheet form the canyon, which binds EV71 receptors D-β

The I β sheet is highly conserved among EV71 subtypes and suitable for drug design

SequenceMWPIAntiviral SP40 (H)QMRRKVELFTYMRFD Strong SP45 (β)AEFTFVACTPTGEVV Weak SP81 (β)KSKYPLVVRIYMRMK Very strong SP81-3 KSKYPLVVRIYMRMKHVR AWI Very strong Table 1 The physical and chemical parameters of the synthetic peptides

Peptides target I-β sheet inhibited cytopathic effects caused by EV71 infections

Cell viability (%) Peptides target I-β sheet protected the viability of cells infected by EV71

Folds of inhibiting viral infection (RNA copies, control/peptide) A B * * ** Peptides target I-β sheet inhibited viral reproduction

3CD? 2A, 3C? Polyprotein Structure Non-structure IRES 5’5’ 1D1B1C1A2A2B2C3A3B3C3D P3 VPg IRES guided translation 2A3CD? VP0 VP3 VP1 VP4VP2 ? 3C? 2A2B2C 3A 3C 3D VPg 3B Proteinase Helicase Polymerase Cleavage P1 P2 The structure of EV71 genome and its encoding proteins

EV71 pseudovirus system

A B Folds of inhibiting virus binding (Luc RNA copies of control/peptides) Folds of reducing Luciferase Activities (Control/peptides) ** * * * * Peptides target I-β sheet inhibited viral infectivity A.Peptides target I-β sheet inhibited the binding of virions to host cells (binding at 4⁰C for 30 min; B. Peptides target I-β sheet inhibited viral entry as indicated By reduced translation expression of luciferase reporter.

SequenceNumberpercentage KSKYPLVVR I YMRMK % KSKYPLV I R I YMRMK % KSKYPLL I R I YMRMK 40.4% KSKYPLV I RMYMRMK 10.1% KSKYPL I VR I YMRMK 20.2% KSKYPL I I R I YMRMK 50.5% KSKYPI VVR I YMRMK 10.1% KSKYPVVVR IYMRMK 10.1% KSKYPLVVRVYMRMK 30.3% KSKYPLVVRTYMRMK 10.1% KSKYPVV I RIYMRMK 10.1% Table 2 The sequences and residue mutation rate of I-β in EV71 circulating worldwide The sequences of SP81-3 (same as the strain outbreaked in 2008 at Fuyang city, Anhui Province, China; GenBank: ACS ). A total of 989 VP1 sequences was recorded in GeneBank and EMBL database by February The mutated residues are shown in red color.The approximately accumulated mutation rate: 247 L to 247 I/V, 0.3%; 248 V to 248 I, 0.7%; 37.4%; 251 I to 251 M/V/T, 0.6%.

SequenceAntiviral SP79RTVGSTKSKYPLVVR - SP80GSTKSKYPLVVRIYM+/- SP81 (β)KSKYPLVVRIYMRMK+++++ SP82YPLVVRIYMRMKHVR++++ SP83VVRIYMRMKHVRAWI++++ SP84VVRIYMRMKHVRAWIPRP- SPC1AAAVVRIYMRMK++ SPC2YPLAAAIYMRMK+ SPC3YPLVVRAAARMK++ SPC4YPLVVRIYMAAA- SPC5YPILIRMYMRMK++++ Table 3 Identification of key residues for EV71 infectivity

Reduction folds of Luciferase Activities (Control/peptides) The antiviral activity of I-β mutants

Key residues canyon Arg 250, Arg 254, Met 255 and Lys 256 are key residues which locate on the Surface and would involve interaction with EV71 receptors

Conclusion  The I β-sheet is an important structure to form the convoy of VP1, which involves receptor binding;  The residues in I β-sheet are highly conserved among subtypes of EV71, therefore, it is an idea structure for drug target;  Peptide targeting I β-sheet potently inhibited EV71 infections;  Residues Arg 250, Arg 254, Met 255 and Lys 256 are critical for virion binding to host cells.

Thank you!